← 產業報告目錄

Spatial Genomics & Transcriptomics Market Size, Share & Trends Analysis Report By Technique (Spatial Transcriptomics, Spatial Genomics Analysis), By Product (Instruments, Consumables, Software), By Application, By End-User, By Region, And By Segment Forecasts, 2025-2034

出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-01-19頁數 185報告編號 INSIGHTACE-8dae625908

授權報價

Single User PDF$4,500 USD
Global Site License PDF$9,500 USD
洽詢購買 申請 Sample

報告摘要

With a 2024 valuation of USD 543.8 Mn, the global Spatial Genomics & Transcriptomics Market is projected to accelerate to USD 1,670.4 Mn by 2034, demonstrating a CAGR of 12.0% during the 2025–2034 forecast window. Spatial Genomics & Transcriptomics covers used to examine the spatial organization and patterns of gene expression in tissues and cells. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space. The market's upward path is bolstered by rising healthcare spending, technological evolution, and the rising focus on personalized and precision-based approaches in healthcare. The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion. Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, bolstered by rapid industrialization and expanding end-user bases. The competitive arena features a mix of established conglomerates and agile innovators, each vying for market position through strategic acquisitions, product launches, and capacity expansion. This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.2. Research Scope & Assumptions Chapter 2. Executive Summary Chapter 3. Global Spatial Genomics Transcriptomics Market Snapshot Chapter 4. Global Spatial Genomics Transcriptomics Market Variables, Trends & Scope 4.1. Market Segmentation & Scope 4.2. Drivers 4.3. Challenges 4.4. Trends 4.5. Investment and Funding Analysis 4.6. Industry Analysis – Porter's Five Forces Analysis 4.7. Competitive Landscape & Market Share Analysis 4.8. Impact of Covid-19 Analysis Chapter 5. Market Segmentation 1: By Technique Estimates & Trend Analysis 5.1. By Technique, & Market Share, 2024-2034 5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Technique: 5.2.1. Spatial Transcriptomics 5.2.1.1. Immunohistochemistry (IHC) 5.2.1.2. In Situ Hybridization 5.2.1.3. Sequencing Technique 5.2.1.3.1. Microdissection-based sequencing 5.2.1.3.2. In situ sequencing 5.2.2. Microscopy-based RNA imaging 5.2.2.1. Other Spatial Transcriptomics Techniques 5.2.2.2. Spatial Genomics Analysis 5.2.3. FLUORESCENCE In Situ Hybridization 5.2.3.1. Sequencing Techniques 5.2.3.2. Other Spatial Genomics Analysis Techniques Chapter 6. Market Segmentation 2: By Application Estimates & Trend Analysis 6.1. By Application & Market Share, 2024-2034 6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Application: 6.2.1. Translational Research 6.2.2. Drug Discovery and Development Chapter 7. Market Segmentation 3: By End-User Estimates & Trend Analysis 7.1. By End-User & Market Share, 2024-2034 7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By End-User: 7.2.1. Academic and Research Institutes 7.2.2. Contract Research Organization 7.2.3. Pharmaceutical and Biotechnology Companies Chapter 8. Market Segmentation 4: By Product Estimates & Trend Analysis 8.1. By Product & Market Share, 2024-2034 8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021-2034 for the following By Product: 8.2.1. Instruments 8.2.2. Consumables 8.2.3. Software Chapter 9. Spatial Genomics Transcriptomics Market Segmentation 5: Regional Estimates & Trend Analysis 9.1. North America 9.1.1. North America Spatial Genomics Transcriptomics Market revenue (US$ Million) estimates and forecasts By Technique, 2021-2034 9.1.2. North America Spatial Genomics Transcriptomics Market revenue (US$ Million) estimates and forecasts By Application, 2021-2034 9.1.3. North America Spatial Genomics Transcriptomics Market revenue (US$ Million) estimates and forecasts By End-User, 2021-2034 9.1.4. North America Spatial Genomics Transcriptomics Market revenue (US$ Million) estimates and forecasts By Product, 2021-2034 9.1.5. North America Spatial Genomics Transcriptomics Market revenue (US$ Million) estimates and forecasts by country, 2021-2034 9.2. Europe 9.2.1. Europe Spatial Genomics Transcriptomics Market revenue (US$ Million) By Technique, 2021-2034 9.2.2. Europe Spatial Genomics Transcriptomics Market revenue (US$ Million) By Application, 2021-2034 9.2.3. Europe Spatial Genomics Transcriptomics Market revenue (US$ Million) By End-User, 2021-2034 9.2.4. Europe Spatial Genomics Transcriptomics Market revenue (US$ Million) By Product, 2021-2034 9.2.5. Europe Spatial Genomics Transcriptomics Market revenue (US$ Million) by country, 2021-2034 9.3. Asia Pacific 9.3.1. Asia Pacific Spatial Genomics Transcriptomics Market revenue (US$ Million) By Technique, 2021-2034 9.3.2. Asia Pacific Spatial Genomics Transcriptomics Market revenue (US$ Million) By Application, 2021-2034 9.3.3. Asia Pacific Spatial Genomics Transcriptomics Market revenue (US$ Million) By End-User, 2021-2034 9.3.4. Asia Pacific Spatial Genomics Transcriptomics Market revenue (US$ Million) By Product, 2021-2034 9.3.5. Asia Pacific Spatial Genomics Transcriptomics Market revenue (US$ Million) by country, 2021-2034 9.4. Latin America 9.4.1. Latin America Spatial Genomics Transcriptomics Market revenue (US$ Million) By Technique, (US$ Million) 2021-2034 9.4.2. Latin America Spatial Genomics Transcriptomics Market revenue (US$ Million) By Application, (US$ Million) 2021-2034 9.4.3. Latin America Spatial Genomics Transcriptomics Market revenue (US$ Million) By End-User, (US$ Million) 2021-2034 9.4.4. Latin America Spatial Genomics Transcriptomics Market revenue (US$ Million) By Product, (US$ Million) 2021-2034 9.4.5. Latin America Spatial Genomics Transcriptomics Market revenue (US$ Million) by country, 2021-2034 9.5. Middle East & Africa 9.5.1. Middle East & Africa Spatial Genomics Transcriptomics Market revenue (US$ Million) By Technique, (US$ Million) 2021-2034 9.5.2. Middle East & Africa Spatial Genomics Transcriptomics Market revenue (US$ Million) By Application, (US$ Million) 2021-2034 9.5.3. Middle East & Africa Spatial Genomics Transcriptomics Market revenue (US$ Million) By End-User, (US$ Million) 2021-2034 9.5.4. Middle East & Africa Spatial Genomics Transcriptomics Market revenue (US$ Million) By Product, (US$ Million) 2021-2034 9.5.5. Middle East & Africa Spatial Genomics Transcriptomics Market revenue (US$ Million) by country, 2021-2034 Chapter 10. Competitive Landscape 10.1. Major Mergers and Acquisitions/Strategic Alliances 10.2. Company Profiles 10.2.1. 10x Genomics 10.2.2. NanoString Technologies 10.2.3. Illumina 10.2.4. Fluidigm Corporation 10.2.5. PerkinElmer 10.2.6. Akoya Biosciences (formerly known as CytoViva) 10.2.7. Spatial Transcriptomics 10.2.8. Dovetail Genomics (Part of Illumina) 10.2.9. S2 Genomics 10.2.10. Visiopharm 10.2.11. MGI Tech Co. Ltd. 10.2.12. CARTANA 10.2.13. RareCyte 10.2.14. Horizon Discovery Group 10.2.15. IONpath

量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們